Emerald Development Managers is an early-stage venture capital firm investing patient capital and expertise in scientific and engineering teams across life sciences, enterprise software, cybersecurity, industrial technology, and sustainability sectors. The firm partners with entrepreneurs to identify trends and build innovative solutions, guiding early-stage companies toward profitability, market share growth, and sustained success. Originating from founders with operational experience and a history of building companies like American Rock Salt, Emerald combines hands-on management with strategic investment to nurture a portfolio of over 20 companies, including leaders in digital pathology, blood testing, cybersecurity, and clean energy. Their approach emphasizes long-term value creation through active involvement and industry expertise, positioning them as a key player in deep tech venture capital.
Investment style
Generalist
Investing team
- Neil CohenFounder & Chairman
- Charles CollinsPartner
- Ian Tolfree, PhDPrincipal
- Cy SchroederPrincipal
- Beckie CohenAssociate
- Youssef KheirallaAssociate